Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Non Operating Investment Income (2017 - 2023)

Updated

Aptevo Therapeutics (APVO) posted Non Operating Investment Income of $9.65 million for FY2023.

Analysis

Aptevo Therapeutics (APVO) Non Operating Investment Income (2017 - 2023) Analysis & Trends

Since FY2017, Aptevo Therapeutics has reported Non Operating Investment Income for 4 years.

  • Annual Non Operating Investment Income shows a four-year compound annual growth rate of 22.8% (FY2019 to FY2023).
  • The FY2023 figure stands as the highest annual Non Operating Investment Income since FY2020.
  • Business Quant data shows APVO's Non Operating Investment Income at $14.34 million in FY2020 (+237.4%) and $4.25 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 9.65 Mn
Mar 31, 2020 14.34 Mn
Dec 31, 2017 159,000.00
API Access

Aptevo Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=APVO&period=max&api_key=YOUR_API_KEY